Get the Stockscreener App
28.09
0.86%
0.205
Kestra Medical Technologies Ltd stock is traded at $28.09, with a volume of 190.47K.
It is up +0.86% in the last 24 hours and up +44.95% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$27.88
Open:
$28.22
24h Volume:
190.47K
Relative Volume:
0.60
Market Cap:
$1.64B
Revenue:
$83.72M
Net Income/Loss:
$-143.89M
P/E Ratio:
-9.9847
EPS:
-2.8128
Net Cash Flow:
$-120.48M
1W Performance:
+10.53%
1M Performance:
+44.95%
6M Performance:
+5.67%
1Y Performance:
+90.64%
1-Day Range:
$27.41
$28.81
1-Week Range:
$25.78
$28.81
52-Week Range:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
28.13 | 1.63B | 83.72M | -143.89M | -120.48M | -2.8128 |
ISRG
Intuitive Surgical Inc
|
426.08 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.25 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.97 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.11 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.78 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | BTIG Research | Buy |
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
KMTS Q4'25 Earnings: revenue estimate is 26.48M USD - TradingView
KMTSKestra Medical Technologies Ltd Options - Finviz
Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488 - Stock Titan
Kestra Medical (KMTS) director and officer acquires 942 ESPP shares - Stock Titan
Kestra Medical Technologies to report Q4FY26 results on July 14 - scanx.trade
Medical Device Leader Kestra Achieves Major Milestone: Added to $10.6T Russell Indexes Post-IPO - Stock Titan
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14 - The Manila Times
Kestra Medical sets July 14 earnings call after market close - Stock Titan
Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 3000 Value Benchmark - marketscreener.com
Kestra Medical Technologies, Ltd.(NasdaqGS:KMTS) dropped from Russell 2500 Value Benchmark - marketscreener.com
Is Kestra Medical Technologies (KMTS) Fully Priced As Sales Expansion Fuels The Bull Case? - simplywall.st
Kestra Medical Insider Sells Common Shares Worth Over $312000 - HarianBasis.co
Kestra Medical Technologies Ltd. Actuals & Estimates (NASDAQ:KMTS) - TradingView
KMTS Forecast — Price Target — Prediction for 2027 - TradingView
What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains - The Motley Fool
Kestra Medical CEO Brian Webster sold $312,142 of shares By Investing.com - Investing.com UK
Kestra Medical Technologies Ltd (KMTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Insider Sell: Brian Webster Sells 15,000 Shares of Kestra Medica - GuruFocus
Kestra Medical CEO Brian Webster sold $312,142 of shares - Investing.com UK
Kestra Medical Technologies Ltd (KMTS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kestra Medical Technologies Insider Sold Shares Worth $312,143, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kestra Medical (NASDAQ: KMTS) director sells 15,000 shares under 10b5-1 plan - Stock Titan
Kestra Medical Technologies Ltd (KMTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kestra Medical Technologies Ltd (KMTS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kestra Medical Technologies Ltd (KMTS) Institutional Confidence - TradingKey
Kestra Medical Technologies Ltd - TradingKey
Kestra Medical Technologies Ltd (KMTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bain Capital Investors LLC Sells 1,846,887 Shares of Kestra Medical Technologies, Ltd. $KMTS - MarketBeat
Kestra Medical Technologies Ltd. (KMTS) Q1 2026 Earnings: EPS Misses Estimates as Company Continues Heavy Investment PhaseBuyback Announcement Report - newsline.com
Kestra Medical (KMTS) insider files show four 15,000-share sales in 2026 - Stock Titan
Kestra Medical Technologies (KMTS) Slightly Lower as Support Levels Are TestedFear Greed Index - newsline.com
Kestra Medical Technologies (KMTS) Holds Near Resistance in Tight Trading RangePCR Extreme - newsline.com
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE) - The Globe and Mail
Kestra Medical Technologies (KMTS) Gains Momentum: Testing Key Resistance After 1.54% UptickResistance Breakout Stocks - newsline.com
Kestra Medical Technologies (KMTS) Dips 2.41% as Shares Approach Key SupportLong Term Entry Picks - dars.gov.et
Kestra Medical Technologies (KMTS) Edges Higher, Nears Key Resistance LevelConversion Trade - newsline.com
Kestra Medical Technologies (KMTS) Slides 5% as Support Levels Come Into FocusETF Outflow Streak - newsline.com
[Form 4] KESTRA MEDICAL TECHNOLOGIES, LTD. Insider Trading Activity - Stock Titan
Kestra Medical (KMTS) Chief Commercial Officer awarded 25,227 RSUs in equity grant - Stock Titan
Kestra Medical (KMTS) CFO receives 25,227 RSUs vesting over three years - Stock Titan
Kestra Medical Technologies (KMTS) grants 25,227 RSUs to director - Stock Titan
Kestra Medical (KMTS) director Webster receives 75,681 RSU equity grant - Stock Titan
Kestra Medical Technologies Ltd. (KMTS) Holds Steady Near Support as Market Digests Recent RangeImbalance Zone - The Legal Advocate
Kestra Medical Technologies (KMTS) Holds Steady Near Resistance as Consolidation ContinuesPCR Spike - newsline.com
Kestra Medical Technologies (KMTS) Holds Steady Near Support, Testing Resistance LevelsCommunity Sell Signals - Newser
Kestra Medical CEO Brian Webster sells $314k in company shares - Investing.com Australia
Director at Kestra Medical (KMTS) sells 15,000 common shares - Stock Titan
Kestra Medical Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Webster Brian Danielmoomoo - Moomoo
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares - sharewise.com
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.39%
2.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):